Type II Alexander disease caused by splicing errors and aberrant overexpression of an uncharacterized GFAP isoform
Authors:
- 11 March 2020
- journal article
- research article
- Published by Wiley in Human Mutation
- Vol. 41 (6) , 1131-1137
Abstract
Alexander disease results from gain of function mutations in the gene encoding glial fibrillary acidic protein (GFAP). At least eight GFAP isoforms have been described, however, the predominant alpha isoform accounts for approximately 90% of GFAP protein. We describe exonic variants identified in three unrelated families with Type II Alexander disease that alter the splicing of GFAP pre‐mRNA and result in upregulation of a previously uncharacterised GFAP lambda isoform (NM_001363846.1). Affected members of Family 1 and Family 2 shared the same missense variant, NM_001363846.1:c.1289G>A;p.(Arg430His) while in Family 3 we identified a synonymous variant in the adjacent nucleotide, NM_001363846.1:c.1290C>A;p.(Arg430Arg). Using RNA and protein analysis of brain autopsy samples, and a mini‐gene splicing reporter assay, we demonstrate both variants result in upregulation of the lambda isoform. Our approach demonstrates the importance of characterizing the effect of GFAP variants on mRNA splicing in order to inform future pathophysiologic and therapeutic study for Alexander disease.Keywords
All Related Versions
This publication has 19 references indexed in Scilit:
- c.1289G>A (p.Arg430His) variant in the epsilon isoform of the GFAP gene in a patient with adult onset Alexander diseaseEuropean Journal of Medical Genetics, 2019
- Predicting Splicing from Primary Sequence with Deep LearningCell, 2019
- Whole Exon Deletion in the GFAP Gene Is a Novel Molecular Mechanism Causing Alexander DiseaseNeuropediatrics, 2017
- Antisense suppression of glial fibrillary acidic protein as a treatment for Alexander diseaseAnnals of Neurology, 2017
- Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanismsActa Neuropathologica, 2017
- CSF and Blood Levels of GFAP in Alexander Diseaseeneuro, 2015
- Neuroimaging and clinical features in type II (late-onset) Alexander diseaseNeurology, 2014
- Splice site, frameshift, and chimericGFAPmutations in Alexander diseaseHuman Mutation, 2012
- Defective Glial Maturation in Vanishing White Matter DiseaseJournal of Neuropathology & Experimental Neurology, 2011
- Identification and characterization of GFAPκ, a novel glial fibrillary acidic protein isoformGlia, 2007